,Chapterq1.qHistoryqofqPharmacology
PharmacologyqClearqandqSimple-
qAqGuideqtoqDrugqClassificationsqandqDosageqCalculationsq4thqEditionqWatkinsqTestqBank
1.
Aqnurseqworkingqinqradiologyqadministersqiodineqtoqaqpatientqwhoqisqhavingqaqcomputedq
tomographyq(CT)qscan.qTheqnurseqworkingqonqtheqoncologyqunitqadministersqchemothera
pyqtoqpatientsqwhoqhaveqcancer.qAtqtheqPublicqHealthqDepartment,qaqnurseqadministersqaq
measles-mumps-rubellaq(MMR)qvaccineqtoqaq14-month-
oldqchildqasqaqroutineqimmunization.qWhichqbranchqofqpharmacologyqbestqdescribesqtheqa
ctionsqofqallqthreeqnurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacologyqisqtheqstudyqofqtheqbiologicqeffectsqofqchemicals.qNursesqareqinvolvedqwithq
clinicalqpharmacologyqorqpharmacotherapeutics,qwhichqisqaqbranchqofqpharmacologyq tha
tqdealsqwithqthequsesqofqdrugsqtoqtreat,qprevent,qandqdiagnoseqdisease.Theqradiologyqnurs
eqisqadministeringqaqdrugqtoqhelpqdiagnoseqaqdisease.qTheqoncologyqnurseqisqadministerin
gqaqdrugqtoqhelpqtreatqaqdisease.qPharmacoeconomicsqincludesqanyqcostsqinvolvedqinqdru
gqtherapy.qPharmacodynamicsqinvolvesqhowqaqdrugqaffectsqtheqbodyqandqpharmacokinet
icsqisqhowqtheqbodyqactsqonqtheqbody.
2.
Aqphysicianqhasqorderedqintramuscularq(IM)qinjectionsqofqmorphine,qaqnarcotic
,qeveryq4qhoursqasqneededqforqpainqinqaqmotorqvehicleqaccidentqvictim.qTheqn
urseqisqawareqthisqdrugqhasqaqhighqabuseqpotential.qUnderqwhatcategoryqwo
uldqmorphineqbeqclassified?
A) ScheduleqI
B) ScheduleqII
C) ScheduleqIII
D) ScheduleqIV
ANSWER: B
, Feedback:
NarcoticsqwithqaqhighqabuseqpotentialqareqclassifiedqasqScheduleqIIqdrugsqbecau
seqofqsevereqdependenceqliability.qScheduleqIqdrugsqhaveqhighqabuseqpotentialq
andqnoqacceptedqmedicalquse.qScheduleqIIIqdrugsqhaveqaqlesserqabuseqpotenti
alqthanqIIqandqanqacceptedqmedicalquse.qScheduleqIVqdrugsqhaveqlowqabuseqpot
entialqandqlimitedqdependenceqliability.
3.
WhenqinvolvedqinqphaseqIIIqdrugqevaluationqstudies,qwhatqresponsibilitie
sqwouldqtheqnurseqhave?
A) Workingq withq animalsq whoq areq givenq experimentalq drugs
B) Choosingq appropriateq patientsq toqbeq involvedq inq theq drugq study
C) Monitoringqandq observingqpatientsq closelyqforq adverseq effects
D) Conductingqresearchqtoqdetermineqeffectivenessqofqtheqdrug
ANSWER: C
Feedback:
PhaseqIIIqstudiesqinvolvequseqofqaqdrugqinqaqvastqclinicalqpopulationqinqwhichqp
atientsqareqaskedqtoqrecordqanyqsymptomsqtheyqexperienceqwhileqtakingqtheqdr
ugs.qNursesqmayqbeqresponsibleqforqhelpingqcollectqandqanalyzeqtheqinforma
tionqtoqbeqsharedqwithqtheqFoodqandqDrugqAdministrationq(FDA)qbutqwouldqn
otqconductqresearchqindependentlyqbecauseqnursesqdoqnotqprescribeqmedicati
ons.qUseqofqanimalsqinqdrugqtestingqisqdoneqinqtheqpreclinicalqtrials.
SelectqpatientsqwhoqareqinvolvedqinqphaseqIIqstudiesqtoqparticipateqinqstudiesqw
hereqtheqparticipantsqhaveqtheqdiseaseqtheqdrugqisqintendedqtoqtreat.qTheseqpat
ientsqareqmonitoredqcloselyqforqdrugqactionqandqadverseqeffects.qPhaseqIqstudie
sqinvolveqhealthyqhumanqvolunteersqwhoqarequsuallyqpaidqforqtheirqparticipatio
n.qNursesqmayqobserveqforqadverseqeffectsqandqtoxicity.
4.
Whatqconceptqisqconsideredqwhenqgenericqdrugsqareqsubstitutedqfo
rqbrandnameqdrugs?
A) Bioavailability
B) Criticalqconcentration
C) Distribution
D) Half-life
ANSWER: A
Feedback: